packageDalbavancin

dalbavancin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dalbavancin is a lipoglycopeptide antibiotic used to treat bacterial skin and soft tissue infections such as cellulitis, including infections caused by MRSA. It is approved and authorised in the European Union, where it is used for these infections.

Summary written by glm-5.3-flash from Wikidata Q5210237 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dalbavancin
ATC codes:J01XA04
DrugBank:DB06219
PubChem CID:23724878
ChEBI:82721
Wikidata:Q5210237
formula:C88H100Cl2N10O28
molar mass:1816.71 g/mol (PubChem CID 23724878)
logP:3.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown